文献速递心力衰竭与心肌病

射血分数保留心衰患者的右室功能与肺循环耦联

Right Ventricular Function and Pulmonary Coupling in Patients With Heart Failure and Preserved Ejection Fraction.
PubMed 文献 · J Am Coll Cardiol · 2023-05-22

该研究基于PARAGON-HF试验中528例有足够超声图像质量的HFpEF患者,评估右室游离壁纵向应变(RVFWLS)及其与估测肺动脉收缩压比值(RVFWLS/PASP)的临床意义。结果显示58%患者存在右室功能障碍(绝对RVFWLS<20%),且RVFWLS及RVFWLS/PASP比值降低与更高的NT-proBNP及心衰住院和心血管死亡复合终点风险独立相关。沙库巴曲/缬沙坦的治疗效应未受右室功能指标影响。

要点

  • HFpEF患者中右室功能障碍常见,绝对RVFWLS<20%者占58%。
  • RVFWLS及RVFWLS/PASP比值降低与NT-proBNP升高及不良预后相关。
  • 右室功能指标未改变沙库巴曲/缬沙坦的治疗效应。

核心结论

  • 在HFpEF患者中,右室功能恶化及其与肺动脉压力的比值降低很常见,并与心衰住院和心血管死亡风险增加显著相关。

研究设计与样本

  • 基于PARAGON-HF试验的回顾性分析,纳入528例有足够超声心动图图像质量的HFpEF患者,平均年龄74±8岁,56%为女性。

主要发现

  • 311例(58%)存在右室功能障碍,定义为绝对RVFWLS<20%。
  • 在388例(73%)三尖瓣环收缩期位移和右室面积变化分数正常的患者中,超过一半显示右室功能受损。
  • RVFWLS和RVFWLS/PASP比值降低与更高的循环NT-proBNP显著相关。
  • 中位随访2.8年期间发生277例心衰住院和心血管死亡;绝对RVFWLS(HR: 1.39; 95%CI: 1.05-1.83; P=0.018)和RVFWLS/PASP比值(HR: 1.43; 95%CI: 1.13-1.80; P=0.002)均与复合终点显著相关。
  • 沙库巴曲/缬沙坦的治疗效应未受右室功能指标影响。

临床怎么用

  • 在HFpEF患者中应关注右室功能及肺循环耦联,RVFWLS和RVFWLS/PASP比值有助于风险分层。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Limited data exist to characterize novel measures of right ventricular (RV) function and the coupling to pulmonary circulation in patients with heart failure and preserved left ventricular ejection fraction (HFpEF). OBJECTIVES: This study sought to assess the clinical implications of RV function, the association with N-terminal pro-B-type natriuretic peptide, and the risk for adverse events among patients with HFpEF. METHODS: This study analyzed measures of RV function by assessing absolute RV free wall longitudinal strain (RVFWLS) and its ratio to estimated pulmonary artery systolic pressure (PASP) (RVFWLS/PASP ratio) in 528 patients (mean age 74 ± 8 years, 56% female) with adequate echocardiographic images quality enrolled in the PARAGON-HF trial. Associations with baseline N-terminal pro-B-type natriuretic peptide and with total HF hospitalizations and cardiovascular death were assessed, after accounting for confounders. RESULTS: Overall, 311 patients (58%) had evidence of RV dysfunction, defined as absolute RVFWLS <20%, and among the 388 patients (73%) with normal tricuspid annular planar systolic excursion and RV fractional area change, more than one-half showed impaired RV function. Lower values of RVFWLS and RVFWLS/PASP ratios were significantly associated with higher circulating N-terminal pro-B-type natriuretic peptide. With a median follow-up of 2.8 years, there were 277 total HF hospitalizations and cardiovascular deaths. Both absolute RVFWLS (HR: 1.39; 95% CI: 1.05-1.83; P = 0.018) and RVFWLS/PASP ratio (HR: 1.43; 95% CI: 1.13-1.80; P = 0.002) were significantly associated with the composite outcome. Treatment effect of sacubitril/valsartan was not modified by measures of RV function. CONCLUSIONS: Worsening RV function and its ratio to pulmonary pressure is common and significantly associated with an increased risk of HF hospitalizations and cardiovascular death in patients with HFpEF. (Efficacy and Safety of LCZ696 Compared to Valsartan, on Morbidity and Mortality in Heart Failure Patients With Preserved Ejection Fraction [PARAGON-HF]; NCT01920711).

来源:J Am Coll Cardiol,查看原文。版权归原作者所有。

引用

  1. Inciardi, Abanda, Shah, et al. Right Ventricular Function and Pulmonary Coupling in Patients With Heart Failure and Preserved Ejection Fraction. J Am Coll Cardiol. 2023. PMID: 37225045. doi:10.1016/j.jacc.2023.05.010

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。